Tianyin Pharmaceutical, Co. was given SFDA approval for a generic version of a statin drug, simvastatin tablets. Simvastatin was developed by Merck, which markets the drug as Zocor. The US patent for the drug expired in 2006. Simvastatin is used to control hypercholesterolemia and treat coronary heart diseases, the only statin approved by the SFDA for these conditions. Tianyin has the ability to produce $2 million of the drug annually. More details...

Stock Symbols: (OTCBB: TYNP) (NYSE: MRK)